What Happened? Shares of global pharmaceutical company Merck (NYSE:MRK) jumped 7.7% in the afternoon session after the Trump ...

Since the market sees this event as broadly positive for pharmaceutical companies, ABBV's stock has risen significantly.

Shares of Merck & Co. Inc. rallied 6.81% to $83.93 Tuesday, on what proved to be an all-around favorable trading session ...

A pair of pharmaceutical giants spearheaded gains for other stocks in the industry on Tuesday, Sept. 30, 2025, while a new ...

Merck KGaA's chief executive Belén Garijo will end her time at the helm of the company next April, five years after taking ...

Despite flat overall Q2 2025 sales, Keytruda's continued strong performance in oncology supports long-term bullish prospects ...

The FDA has approved Keytruda Qlex, a faster, under-the-skin cancer treatment offering convenience and flexibility. Here's ...

The U.K. has had a stronghold on the biopharma and healthcare industry for a long time and remains one of the top hubs for ...

Evaxion (EVAX) stock soars as Merck (MRK) licenses its vaccine candidate EVX-B3 in a deal worth up to $600M. Read more here.

For the last two years, Keytruda has reigned as the world’s top-selling drug—a distinction under threat with key patent ...

The U.S. Food and Drug Administration said on Friday it has approved a new formulation of Merck's blockbuster cancer therapy ...

COPD encompasses other respiratory conditions It takes people with COPD longer to exhale all the air from their lungs, often because of narrowing and damage in the airways. COPD i ...